Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters - Fierce Pharma
Source: Fierce Pharma ·
Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters Fierce PharmaEXCLUSIVE: Major Novartis shareholder calls for board shake-up after drug trial setbacks ReutersNovartis Sees Avidity Drug Fail in Third Setback in a Week Bloomberg.comPharma major Novartis falls 10% after three drug trial setbacks CNBCNovartis RNA drug falls short in rare muscle disease study…
BestAIBroker analysis
- Finance-aware sentiment: negative (-0.40 on a -1 to +1 scale).
- Event classification: OTHER.
- Market importance score: 25/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
- Symbols referenced: RNA.